greeksoup/ stock research

Hamilton Beach Brands Holding Co.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 25 February 2026: press release. Guidance figures: 4 new. The quarter’s numbers.

Key takeaways

  • Fourth-quarter revenue held flat: Fourth-quarter revenue was $212.9 million, roughly flat with $213.5 million a year earlier. Commercial and Health growth offset lower U.S. Consumer volumes. Source
  • Full-year revenue fell 7.3%: Full-year revenue declined 7.3% to $606.9 million from $654.7 million. Management attributed the decline mainly to lower U.S. Consumer volumes in the second and third quarters. Source
  • Full-year operating profit declined: Operating profit fell to $36.6 million for 2025, while fourth-quarter operating profit rose 8.0% to $25.4 million. Source
  • Sequential improvement from Q2 and Q3: Management described fourth-quarter sales as a significant sequential improvement from the double-digit declines in the second and third quarters. Source
  • Fourth-quarter gross margin reached 28.3%: Fourth-quarter gross margin was 28.3%, up from 26.1%. Management attributed the increase to product and customer mix from the higher-margin Commercial and Health businesses. Source
  • One-time tariff cost cut full-year margin: A one-time incremental tariff cost of $5.3 million reduced full-year gross margin by 90 basis points. Most of it came from China tariff rates reaching 125%. Source
  • Operating cash flow fell to $13.8M: Operating cash flow was $13.8 million for 2025, down from $65.4 million, mainly on higher working capital. Source

“We are pleased with our fourth quarter results, which meaningfully exceeded our expectations and represent an important step forward in our recovery from the tariff-related disruptions we faced in 2025,”

R. Scott Tidey, President and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Gross margin Source2026 full yearsimilar to slightly better than 2025's levelNew
Advertising spend Source2026incremental $6 millionNew
Accelerated depreciation (legacy ERP system) Source2026approximately $6 millionNew
Operating cash flow less investing cash used Source2026 full year$35 million to $45 millionNew

What changed from last quarter

  • New guidance: The prior release gave no specific guidance. The current release gives 2026 ranges for revenue, gross margin, reported operating profit and operating cash flow less investing.
  • Ended: The Bartesian licensing agreement expired at the end of 2025. Source
  • New: The company's agreements list now names Sunkist commercial juicers and sectionizers, in place of Bartesian cocktail makers. Source

Fourth quarter and full-year results

  • Fourth-quarter revenue held flat: Fourth-quarter revenue was $212.9 million, roughly flat with $213.5 million a year earlier. Commercial and Health growth offset lower U.S. Consumer volumes. Source
  • Full-year revenue fell 7.3%: Full-year revenue declined 7.3% to $606.9 million from $654.7 million. Management attributed the decline mainly to lower U.S. Consumer volumes in the second and third quarters. Source
  • Full-year operating profit declined: Operating profit fell to $36.6 million for 2025, while fourth-quarter operating profit rose 8.0% to $25.4 million. Source
  • Diluted EPS down to $1.95: Diluted earnings per share were $1.95 for 2025 against $2.20 in 2024. Net income was $26.5 million for the year, against $30.8 million. Source

Demand, segments and sourcing

  • Commercial and Health revenue grew: Commercial and Health revenue grew in the fourth quarter and the full year, partly offsetting U.S. Consumer declines. Management described these businesses as higher margin. Source
  • Health unit expanding medical reach: Hamilton Beach Health, which owns HealthBeacon, is described as expanding the company's presence in home health and medical markets through connected devices. Source
  • Sourcing and pricing moves cited: Management cited diversifying the sourcing base, select price adjustments, and growth in commercial and health segments as actions behind the recovery. Source
  • Sequential improvement from Q2 and Q3: Management described fourth-quarter sales as a significant sequential improvement from the double-digit declines in the second and third quarters. Source

“We entered 2026 with building momentum and renewed confidence in our ability to deliver sustainable growth and shareholder value.”

R. Scott Tidey, President and Chief Executive Officer

Costs, margins and tax

  • Fourth-quarter gross margin reached 28.3%: Fourth-quarter gross margin was 28.3%, up from 26.1%. Management attributed the increase to product and customer mix from the higher-margin Commercial and Health businesses. Source
  • One-time tariff cost cut full-year margin: A one-time incremental tariff cost of $5.3 million reduced full-year gross margin by 90 basis points. Most of it came from China tariff rates reaching 125%. Source
  • Fourth-quarter SG&A rose on incentives: Fourth-quarter SG&A rose to $34.7 million, mainly from higher performance-based compensation tied to results above earlier expectations, plus $1.5 million more advertising. Source
  • Effective tax rate rose to 25.8%: The 2025 effective tax rate was 25.8%, against 7.8% in 2024. The 2024 rate included a foreign tax benefit and a U.S. accounting method change that did not recur. Source

Cash flow and working capital

  • Operating cash flow fell to $13.8M: Operating cash flow was $13.8 million for 2025, down from $65.4 million, mainly on higher working capital. Source
  • Working capital absorbed cash: Management said working capital rose, including lower accounts payable as the company anniversaried the 2024 inventory builds. Source
  • Lower taxes payable under OBBBA: Income taxes payable were lower in 2025 because of The One Big Beautiful Bill Act (OBBBA). Lower incentive payables also reduced other liabilities. Source

“Our diversified business model, strong brand portfolio, and the work we’ve done strengthening our foundation, positions the company to capitalize on the improving market conditions this year”

R. Scott Tidey, President and Chief Executive Officer

Debt and shareholder returns

  • Buybacks and dividends in 2025: The company repurchased 506,925 Class A shares for $9.0 million and paid $6.4 million in dividends during 2025. Source
  • Total debt and net debt at year-end: Total debt was $50.0 million at year-end 2025, with net debt of $2.7 million. Source
  • Net debt was $32.8 million in September: At September 30, 2025, total debt was $50.0 million and net debt was $32.8 million, compared with $22.5 million a year earlier.

Systems, licensing and strategy

  • Legacy ERP system charge in fourth quarter: Fourth-quarter SG&A included a charge for writing off and accelerating depreciation of the legacy enterprise resource planning system. Source
  • Platform for long-term growth: Management said the diversified model, brand portfolio and foundation work position the company to capitalize on improving 2026 market conditions. Source
  • Sunkist juicer agreement listed: The About section lists multiyear agreements for Numilk and Sunkist commercial juicers, with Bartesian no longer listed. Source

Coming up, as management said on 25 February 2026

  • Working capital normalization in 2026: Management said the 2026 cash flow guidance reflects an outsized increase from normalizing tariff-related net working capital effects. Source

Risks management discussed

  • External: Tariff rates on imports from China, reaching 125%, drove most of the one-time 2025 cost. Source
  • Demand: Retailers paused buying to assess inventory levels and tariff-driven price increases, reducing U.S. Consumer volumes. Source
  • Regulatory: Changes in tax law under The One Big Beautiful Bill Act lowered income taxes payable in 2025. Source
  • Operational: The legacy ERP system write-off and accelerated depreciation add costs in 2025 and about $6 million more in 2026. Source

Earlier plans management reported on

  • Not stated: In the prior release, management expected brand strength, sourcing diversification and pricing actions to drive further top-line and margin recovery in the fourth quarter.

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.